Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

VA New England Healthcare System

 

Clinical Trials Network Consortia

Oncology Consortium

The Oncology Consortium focuses on developing cancer care within the Network and opening national-level clinical trials in VISN1 VA hospitals. This group maintains an active membership in the Southwest Oncology Group (SWOG) that allows VA patients access to National Cancer Institute trials.

  • Consortium Lead: Michal Rose, MD

Mental Health Consortium

The primary aim is to support VISN1 veterans by expanding access to mental health research studies through a collaborative approach between all VISN1 medical centers. Additionally, the consortium is closely aligned with the Career Development award to assist early career investigators within VISN1 to obtain VA funding.

  • Consortium Lead: Kelly Harrington, PhD

Women’s Health Consortium

The primary aim is to develop a VISN-wide network of women’s health research to improve access to VA and community-based care, improve health outcomes and provide opportunities for women Veterans to participate in clinical trials.

  • Consortium co- lead: Kristin Mattocks , PhD
  • Consortium co- lead: Lori Bastian, MD

Military Toxic Exposure Consortium

The primary aim of the CTN Toxic Exposure Consortium is to ensure Veterans in VISN 1 can contribute to and benefit from research regarding the health effects of toxic exposures. Prior CTN Consortia – the Oncology and cardiology Consortia, and notably the Research Precision Oncology Program (REPOP) – have demonstrated how partnership between the clinical and research arms of the VA lays the foundation for a rapid learning healthcare system. Given the current lack of knowledge about the health consequences of toxic exposures, this partnership continues to be critical to best serve Veterans who experienced toxic exposures during their service.

  • Consortium co- lead: Gaurav Chaudry, MD
  • Consortium co- lead: Jacob Joseph, MD

Cardiology Consortium

The VISN1 Cardiology Consortium is a unique initiative with the goals of expanding clinical cardiology research, advancing patient care, and supporting quality improvement across VA sites in the network.  We plan to capitalize on each site’s individual interests and unique strengths to form a strong collaborative group focused on research and the care of the VA’s distinctive population.

  • Consortium Lead: Nishant Shah, MD
return to top go